Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects

NCT01903824 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Cognitive Impairment

Interventions

DRUG: CEP-26401
DRUG: donepezil hydrochloride
DRUG: modafinil
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.